Pfizer to launch trial of Omicron-targeted COVID vaccine
The company has said that two doses of the original vaccine may not be sufficient to protect against infection from Omicron.
Full Article
Pfizer to launch trial of Omicron-targeted COVID vaccine
Brisbane Times
0 shares
1 views
You might like
Related news coverage
U.S. Gives Full Approval To Moderna's COVID-19 Vaccine
Newsy
Watch VideoU.S. health regulators on Monday granted full approval to Moderna's COVID-19 vaccine, a shot that's already been given..
Advertisement
More coverage
-
Pfizer-BioNTech begin clinical trials of Covid-19 vaccine specific to Omicron variant
DNA
-
Pfizer Human Trials for Omicron-Specific COVID-19 Vaccine Begins: Full Details
HNGN
-
The latest on the coronavirus pandemic and the Omicron variant
Upworthy
-
Pfizer And BioNtech Begin Clinical Trial For Omicron-Specific COVID-19 Vaccine
cbs4.com